Hmmm... not the most inspiring earnings report or CC. Even after the writeoff we're still a value play here, HOWEVER, TGX is always a value play and that has done little to help the shareholder. Is it a buy here? Could be, but my experience says a true value play needs a catalyst of some kind to move forward and after thoese earnings and conf call, not sure I see one? Anyone disagree??
CEO. “In particular, the acquisition of NeedleTech furthers our diversification strategy and provides access to new markets and applications across our entire asset base. The implementation of our research and development program should support continued growth.”
Is this Christine's catalyst or is it just a poor excuse for a catalyst?
But they paid a very high price for that catalyst. Around 3x sales - is that correct? So considering the super value that TGX trades at, assuming it stays here, I suppose they are "diluting" their new purchase right off the bat since that will be folded into TGX at these super low prices.....